Save $$$ on Clarinex purchased online

By Bernard J. Wolfson, The Orange County Register, Calif. Knight Ridder/Tribune Business News
Aug. 7–Sarah Gerrick of Santa Ana was dismayed recently when her family’s health insurer, Health Net Inc., informed her of a sharp increase in the copayment for Allegra, a pr…

Schering-Plough earlier this month lost its appeal of a U.S. court decision that found generic equivalents to the company’s Claritin (loratadine) drug were not in violation of patents protecting Clarinex (desloratadine).

Most Popular
10 Jobs That Pay $30 An Hour
Public Speaking: 7 Secrets Of Great Public Speakers
13 Job In…

M2 PRESSWIRE-25 June 2007-Biotech News: Shareholders alert for Schering-Plough Corp(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:25062007 Shareholders alert for Schering-Plough Corp (NYSE:SGP) Schering-Plough Corporation engages in the discovery, dev…

Most Popular
5 Regular Mistakes In Public Speaking
3 Questions No Job Seeker Ever Wants To Be Asked?
13 Job Interview Mistakes To Avoid
How To Get A Job Offer From Every Interview
10 Jobs That Pay $30 An Hour

> Schering-Plough Corp. is cutting 1,100 jobs, closing one plant in Puerto …

Clarinex-D 12 Hour is now available over the counter for relief of nasal and non-nasal symptoms of seasonal allergic rhinitis in patients aged 12 years and older. The tablets …

Most Popular
How To Get A Job Offer From Every Interview
10 Jobs That Pay $30 An Hour
3 Questions No Job Seeker Ever Wants To Be Asked?
5 Regular Mistakes In Public Speaking
13 Job Inter…

Schering-Plough, marketer of high-profile allergy products Claritin and Clarinex, last month decided not to exercise its option agreement related to ALK-Abello’s grass-pollen allergy tablet and other non-injectable allergy products, the company reported.
ALK-Abello has reacquired the exclusive worldwide. rights to these products, ending the collaboration the two companies entered in October 2002.

Related Results
…

WASHINGTON–The National Consumers League (NCL) wants the Food and Drug Administration to keep Clarinex as a prescription-only product. The medication reached the market in January.

Earlier this year WellPoint Health Networks Inc. filed a petition with the regulatory agency to gain approval for an over-the-counter version of the Schering-Plough Corp. allergy product.

Related Results
…

Business Editors
PARSIPPANY, N.J.–(BUSINESS WIRE)–Nov. 14, 2002
CommonHealth today announced that The Quantum Group, its agency dedicated exclusively to building consumer healthcare brands, was awarded “Agency of the Year” honors by the DTC (direct-to-consumer) Perspectives magazine reader’s poll.
The company’s work was also recognized …

Newswire as we go to press
> A heavy DTC promotion program is expected to highlight the Schering-Plough effort to switch Claritin users to Clarinex before Claritin loses patent protection in December 2002 and generic versions are marketed. The drug was cleared for marketing by the FDA on December 21, 2001.

Most Popular
Public Speaking: 7 Secrets Of Great Public Speakers
5 Regular Mistakes In Public Speaking
3 Qu…

Mo. The FDA’s approval of Schering’s Clarinex (desloratadine) on December 21 for “the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older” broke an internal policy precedent by being based not on an FDA preapproval inspection of the plant that will make the drug, but on an audit of that plant done for Schering by an outside consultant. The facility, in Las Piedras, Puerto Rico, was audited by Lachman Consultant Service…